The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

We addressed the Trump administration’s concerns about fentanyl trafficking and appointed a “fentanyl czar” (who hasn’t been ...

Bil Schmidtknecht blames pharmacy benefit managers for the death of his son. He won’t rest until he holds them accountable.

President Donald Trump recently signed a new executive order advancing a “most favored nation” approach to drug pricing. The ...